Knowledge Papers

HOW COSTLY ARE YOUR DATA?

Clinical trial costs are spiralling out of control. Studies generally estimate the cost of bringing an Investigational new drug (IND) to market at $1B although there is considerable variability in such estimates. Data handling and pickup costs related to patient records account for a staggering 30 percent of drug development costs. This is just the beginning of the cost of non-compliance – for more details, refer to “Medication Non-Compliance”, “How Valid Are Your Clinical Trials Data?” and “Are Patient Reports Accurate?”